FLT4 - fms related receptor tyrosine kinase 4 Gene
Also Known as PCL; CHTD7; FLT-4; FLT41; LMPH1A; LMPHM1; VEGFR3; VEGFR-3
Species: Homo sapiens
About FLT4
This gene has 12 transcripts (splice variants), 196 orthologues, 53 paralogues and is associated with 131 phenotypes. Broad expression in spleen (RPKM 7.7), lung (RPKM 6.7) and 21 other tissues.
Summary
This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008]
FLT4 Products (10)
| mRNA | Protein | Name |
|---|---|---|
| NM_182925.5 | NP_891555.2 | vascular endothelial growth factor receptor 3 isoform 1 precursor |
| XM_047417002.1 | XP_047272958.1 | vascular endothelial growth factor receptor 3 isoform X5 |
| XM_017009268.2 | XP_016864757.1 | vascular endothelial growth factor receptor 3 isoform X4 |
| XM_017009263.2 | XP_016864752.1 | vascular endothelial growth factor receptor 3 isoform X2 |
| NM_002020.5 | NP_002011.2 | vascular endothelial growth factor receptor 3 isoform 2 precursor |
| XM_011534484.3 | XP_011532786.1 | vascular endothelial growth factor receptor 3 isoform X7 |
| XM_017009266.2 | XP_016864755.1 | vascular endothelial growth factor receptor 3 isoform X3 |
| NM_001354989.2 | NP_001341918.1 | vascular endothelial growth factor receptor 3 isoform 3 precursor |
| XM_047417003.1 | XP_047272959.1 | vascular endothelial growth factor receptor 3 isoform X6 |
| XM_011534478.4 | XP_011532780.1 | vascular endothelial growth factor receptor 3 isoform X1 |
FLT4 Protein Structure
Ig_2: Immunoglobulin domain (34 - 115)
I-set: Immunoglobulin I-set domain (238 - 327)
Ig_2: Immunoglobulin domain (361 - 410)
Ig_2: Immunoglobulin domain (431 - 542)
Ig_2: Immunoglobulin domain (560 - 659)
I-set: Immunoglobulin I-set domain (678 - 765)
Pkinase_Tyr: Protein tyrosine kinase (845 - 1169)
- 0
- 300
- 600
- 900
- 1200
- 1363 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
vascular endothelial growth factor receptor 3 |
|
|
FLT4 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
FLT4 | P35916 | KDR | Homo sapiens | P35968 | 16530705 | |
|
Intra
|
FLT4 | P35916 | VEGFC | Homo sapiens | P49767 | 21130043 | |
|
Intra
|
FLT4 | P35916 | HSP90AB1 | Homo sapiens | P08238 | 22939624 | |
|
Intra
|
FLT4 | P35916 | HSP90AB1 | Homo sapiens | P08238 | 22939624 | |
|
Intra
|
FLT4 | P35916 | HSP90AB1 | Homo sapiens | P08238 | 35384245 |
Recombinant FLT4 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P74468 | VEGFR-3/FLT4 Protein, Human (HEK293, His) | P35916-2/NP_002011.2 (Y25-I776) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P74469 | VEGFR-3/FLT4 Protein, Human (HEK293, hFc) | P35916-2/NP_002011.2 (Y25-I776) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P78538 | VEGFR-3/FLT4 Protein, Human (HEK293, His-Avi) | P35916-1 (Y25-I776) | ≥ 95%, as determined by Bis-Tris PAGE. |
| HY-P78872 | VEGFR-3/FLT4 Protein, Human (Biotinylated, HEK293, His-Avi) | P35916-1 (Y25-I776) | ≥ 95%, as determined by reducing SDS-PAGE. |
FLT4 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P810814 | VEGFR3 Antibody (YA10057) | WB, IHC-P, FC | Human |
| HY-P85169 | VEGFR3 Antibody (YA4861) | WB, IHC-P | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Pancreatic Cancer |
|
|
| Hemangioendothelioma |
|
|
| Hemangioma, Capillary Infantile |
|
|
| Familiar Ovarian Carcinoma |
|
|
| Breast Angiosarcoma |
|
|
| Hobnail Hemangioma |
|
|
| Lymphatic Malformation 5 |
|
|
| Adenocarcinoma |
|
|
| Pyriform Sinus Cancer |
|
|
| Hennekam Syndrome |
|
|
| Kaposi Sarcoma |
|
|
| Hereditary Lymphedema |
|
|
| Mesothelioma, Malignant |
|
|
| Lymphatic Malformation 1 |
|
|
| Lymphedema-Distichiasis Syndrome |
|
|
| Lung Cancer Susceptibility 3 |
|
|
| Sarcoma |
|
|
| Renal Cell Carcinoma, Nonpapillary |
|
|
| Hemangioma |
|
|
| Angiosarcoma |
|
|
| Tetralogy Of Fallot |
|
|
| Elephantiasis |
|
|
| Melanoma |
|
|
| Congenital Lymphedema |
|
|
| Rapidly Involuting Congenital Hemangioma |
|
|
| Colorectal Cancer |
|
|
| Breast Cancer |
|
|
| Capillary Hemangioma |
|
|
| Gastric Cancer |
|
|
| Generalized Lymphatic Anomaly |
|
|
| Squamous Cell Carcinoma, Head And Neck |
|
|
| Cystic Lymphangioma |
|
|
| Vascular Cancer |
|
|
| Chylothorax, Congenital |
|
|
| Cardiovascular Organ Benign Neoplasm |
|
|
| Lymphangitis |
|
|
| Lung Cancer |
|
|
| Congenital Heart Defects, Multiple Types, 7 |
|
|
| Hereditary Lymphedema I |
|
|
| Epithelioid Hemangioendothelioma |
|
|
| Hereditary Lymphedema Ia |
|
|
| Urethra Transitional Cell Carcinoma |
|
|
| Lymphangioma |
|
|
| Hypotrichosis-Lymphedema-Telangiectasia Syndrome |
|
|
| Klippel-Trenaunay-Weber Syndrome |
|
|
| Prostate Cancer |
|
|
| Lymphangiosarcoma |
|
|
| Right Aortic Arch |
|
|
| Ovarian Cancer |
|
|
| Spindle Cell Sarcoma |
|
|
| Childhood Angiosarcoma |
|
|
| Exudative Vitreoretinopathy 1 |
|
|
| Hemifacial Spasm |
|
|
| Gastrointestinal Stromal Tumor |
|
|
| Primary Lymphedema |
|
|
| Cellulitis |
|
|
| Hypotrichosis |
|
|
| Gorham'S Disease |
|
|
| Pyogenic Granuloma |
|
|
| Hydrocele |
|
|
| Laryngeal Squamous Cell Carcinoma |
|
|
| Vascular Disease |
|
|
| Capillary Lymphangioma |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Mus musculus | FLT4 | MGD | MGI:95561 |
| Felis catus | FLT4 | VGNC | VGNC:62301 |
| Macaca mulatta | FLT4 | VGNC | VGNC:72681 |
| Canis familiaris | FLT4 | VGNC | VGNC:40910 |
| Bos taurus | FLT4 | VGNC | VGNC:29044 |
| Rattus norvegicus | FLT4 | RGD | RGD:621737 |
| Others | FLT4 | NCBI |